scorecardresearch
Monday, November 4, 2024
TopicPfizer vaccine

Topic: Pfizer vaccine

8,200 syringes/min — how this Indian firm is helping in vaccinating the world against Covid

Haryana-based Hindustan Syringes & Medical Devices has been looking to meet the world's demand for syringes amid the global Covid-19 vaccination drive. 

Brazil’s hospital woes, allergic reaction to Pfizer in Japan & other global Covid-19 news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Single dose of Pfizer, AstraZeneca vaccines effective, work against UK variant too — Study

The study by Public Health England aimed at arriving at a real world estimation of how effective the two vaccines are and covered all adults in England aged 70 years and above.

Will convince Modi govt to bring back Pfizer vaccine, it will add value: CSIR chief Mande

India will need at least 4 other vaccines to help finish immunisation drive faster, and J&J, Moderna, Sputnik are good options along with Pfizer, CSIR head Shekhar Mande says.

Pfizer-BioNTech vaccine could help end Covid pandemic, Israel study shows

Two doses prevented 94% of Covid-19 cases in 596,618 people vaccinated between 20 Dec and 1 Feb, teams from Clalit Research Institute and Harvard University reported in a study.

Why Pfizer’s Covid vaccine was not granted emergency use approval by govt’s expert panel

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Pfizer vaccine can neutralise Covid variants first reported in UK, South Africa, study says

The research, published in Nature Medicine journal, noted that neutralisation against Covid variant carrying E484K mutation was slightly lower than that against the N501Y mutation.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

Pfizer withdraws application for emergency use of its Covid vaccine in India

Pfizer says it will resubmit its approval request with additional information as it becomes available in the near future.

WHO says Pfizer vaccine safe for elderly despite Norway scare

The WHO panel said reports of deaths 'are in line with the expected, all-cause mortality rates' & risk-benefit balance of the vaccine 'remains favorable in the elderly'.

On Camera

Trudeau is nursing snakes in his own backyard. Misguided Sikhs in Canada are losing the plot

By turning a blind eye to the snakes in his own backyard, Trudeau is setting the stage for a disaster of epic proportions for his country, his people, and the world at large.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

India carries out 1st patrol in Depsang since disengagement with China, to take things ‘slow’

While there are patrolling points (PP) 10, 11, 12, 12A and 13 in the Depsang Plains, the patrol in the region Monday was carried out to only one point as decided by India and China.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.